Our findings are consistent with recent work in human postmortem tissue that compared microglia reactivity between mixed pathology (DLB+AD) brains and pure pathology brains, showing higher levels of CD68+, reactive microglia in the hippocampus with mixed pathology (van Wetering et al., 2024). The gene discussed is CD68; the disease is Alzheimer disease.